Skip to content

Age-dependent criteria (based on regional agreement):

  • Birth to < 48 hrs of life: 45mg/dL
  • ≥ 48 hrs of life: 60mg/dL

Family Care Center approach to hypoglycemia screening

Section titled “Family Care Center approach to hypoglycemia screening”

[Download]

  • GA < 37 weeks
  • BW ≥ 4,000g
  • BW ≤ 2,500g
  • IDM
  • Other infants identified at the discretion of the provider

Goal: Glucose ≥ 35 mg/dL

Hypoglycemia screening guidelines for asymptomatic at risk newborns: 0-4 hours

Hypoglycemia screening guidelines for asymptomatic at risk newborns: 0-4 hours

Goal: Glucose ≥ 45 mg/dL

Hypoglycemia screening guidelines for asymptomatic at risk newborns: 0-4 hours

Hypoglycemia screening guidelines for asymptomatic at risk newborns: 0-4 hours

Consider obtaining critical laboratory tests for infants requiring a glucose infusion rate greater than 10 mg/kg/min, when, based on gestational and chronological age, they would not typically require intravenous fluids.

  • Tier 1
#IDCodeDescriptionTubeVolume
182947ASerum glucosePST4 green top0.4ml
283525BInsulinGLD6 gold top0.4ml
382533ACortisolGLD6 gold top0.4ml
482010ABeta-hydroxybutyric acidGLD6 gold top1ml
583003BHuman growth hormoneRED7 red top1ml
680051PElectrolyte panelPST4 green top0.2ml
  • Tier 2
#IDCodeDescriptionTubeVolume
184210BPyruvic acidSpecial tube/handling instructions:
contact lab
1ml
282140BAmmoniaSpecial tube/handling instructions:
contact lab
0.4ml
382024BACTHSpecial tube/handling instructions:
contact lab
1ml
482533UCortisol, NeonatalRED7 red top0.4ml
584443BTSHGLD6 gold top0.4ml
684439BT4, freeGLD6 gold top0.4ml
782725BFree fatty acidsRED7 red top0.6ml
882017BAcylcarnitine profile, plasmaGRN5 green top1ml
982139CAmino acids, plasmaGRN5 green top2ml
1083918COrganic acids, urineUrine container15ml
  • Tier 3

    Blood gas for pH, BE, and lactate

Capillary:

  • Heel stick

Venous:

  • Freshly placed PIV
  • UVC
  • PowerPICC (not routinely seen in our NICU)

Arterial:

  • Radial/ulnar artery puncture
  • UAC
  • PAL

Procedure for inducing hypoglycemia (need to discuss further)

Section titled “Procedure for inducing hypoglycemia (need to discuss further)”
  1. Identify the lab tests, verify order entry.
  2. Determine the total volume needed.
    Physicians should be mindful of the practicality of the exsanguinated volume.
  3. Identify the source of blood specimen.
  4. D10W 2mL/kg bolus syringe available at bedside.
  5. Discontinue IV fluid.
  6. Check POC glucose every 30min until level < 55mg/dL.
  7. Check POC glucose every 15min until level < 45mg/dL.
  8. Obtain blood specimen.
  9. Check POC glucose. If < 40mg/dL, administer D10W 2mL/kg bolus once.
  10. Restart IV fluid.
  11. Check POC glucose every 30min until > 60mg/dL.
Need consensus
  • Wean by 2ml/hr for AC POC Glucose >80 (or 75)
  • Wean by 1mL/hr for AC POC Clugose 70-80 (or 65-75)
  • Increase by 1mL/hr for AC POC glucose 50-60 (or 45-55)
  • Increase by 2mL/hr for AC POC Glucose < 50 (or <45), and notify MD
  • Once off IV, continue to check sugars until >60 on 3 consecutive checks.

Secondary Screening for Neonatal Thyroid Conditions

Section titled “Secondary Screening for Neonatal Thyroid Conditions”
IndicationScreening needed
Monochorionic twins/Multiple (Same-sex if chorionic status not known)TSH at 2 weeks of age
ANY congenital heart disease diagnosis (exclude PDA) with infant hospitalized to at least day 14TSH at 2 weeks of age
Very low birth weight (≤ 1500 grams)TSH at 2, 4, and 6 weeks of age if still hospitalized
Down syndromeTSH at 2 weeks
Mother with history of or active hyperthyroidism/Graves diseaseSee: Managing Neonatal Graves Disease flowchart
Signs or symptoms of hypothyroidism (e.g., unexplained lethargy, bradycardia, jaundice, or constipation; abnormal neck imaging)TSH and Free T4 as soon as symptoms are recognized
Signs or symptom of central hypothyroidism or hypopituitarism (e.g., craniofacial/midline defects, certain genetic syndromes, recurrent hypoglycemia, recalcitrant hypotension, micropenis)TSH and free T4 along with other pituitary tests when signs or symptoms are recognized
Mother with hypothyroidism or Hashimoto thyroiditis and no history of Graves diseaseRoutine newborn screen only

Guide for interpretation of thyroid function studies

Section titled “Guide for interpretation of thyroid function studies”

TSH

  • Hypothyroidism screening: < 10mIU/L
  • maternal Graves/hyperthyroidism: use lab-provided reference

Free T4

  • Use lab-provided reference

TSH

  • Newborn ≤ 3 days old: 1-20 mIU/L
  • Newborn > 3 days old: use lab-provided reference

Free T4

  • Newborn ≤ 14 days old: 1.4-2.8 ng/dL
  • Newborn > 14 days old: use lab-provided reference

Screening Guidelines for Neonatal Graves Disease

Section titled “Screening Guidelines for Neonatal Graves Disease”
flowchart TD
  A["Mom with Graves Disease (hyperthyroidism) or history of Graves disease (hyperthyroidism)"] --> B["Obtain Thyroid Receptor Ab (TR Ab) or TSI in 2<sup>nd</sup>/3<sup>rd</sup> Trimester"]
  B --> C["Positive or unknwon TR Ab/TSI or<br>Negative TR Ab but active maternal hyperthyroidism<br><em>and/or</em><br>Treated with anti-thyroid drugs (PTU/methimazole)"]
  B --> D["NO current anti-thyroid treatment<br><em><u>and</u></em><br>NEGATIVE TR Ab/TSI in 2<sup>nd</sup>/3<sup>rd</sup> Trimester"]
  C --> E[High risk neonate]
  D --> F[No screening needed]
  E --> G["Obtain TR Ab/TSI in cord blood or nursery<br><em>If not done</em>: Order TR Ab/TSI, freeT4, TSH for outpatient draw in first 7 days of life"]
  G --> H["+ TR Ab/TSI = High risk neonate<br><em>(Observe for clinical symptoms of hyper/hypothyroidism)</em>"]
  G --> I["Negative TR Ab/TSI = Low risk neonate"]
  H --> J["Draw TSH and free T4 at 3-7 days<br><em>(if not done prior, or if symptomatic)</em>"]
  I --> K["No further work-up necessary"]
  J --> L["Abnormal results: send Dr. Advice to Peds Endo<br><em>(TSH < 1mIU/ml and/or free T4 > 2ng/dl is abnormal)</em>"]
  J --> M["Normal TSH, free T4 for age"]
  M --> K
  • Defects in gene producing transcription factors along the pathway of testicular differentiation
  • Defects in androgen synthesis & production
  • Defect in androgen receptor response
  • Disrupted müllerian inhibition
  • Gonadal overproduction of androgens due to mutations involved in gonadal (ovarian) development
  • Adrenal overproduction of androgens
  • Placental aromatase deficiency
  • Maternal exogenous exposure to androgens

Male

  • micropenis:
    • Full-term: stretched penile length < 2.5cm
    • Preterm: normal stretched penile length (cm) = -2.27 + 0.16 x GA in week
  • severe hypospadias (with or without cryptorchidism or micropenis)

Female

  • clitoromegaly: width > 6mm or length > 9mm
  • posterior labial fusion, with anogenital ratio > 0.5
  • gonads palpable in the labioscrotal folds or the inguinal region

STAT ORDERS

  • Serum eletrolytes
  • Serum glucose level
  • Random cortisol
  • 17-OHP: value affected by prematuirty, maternal steroid intake
  • Renin
  • Karyotyping

ROUTINE ORDERS

  • Ultrasound of the abdomen/pelvis
  • Growth hormone level (in the first 15 days of life)
  • Prolactin (can help diagnose growth hormone deficiency)
  • Free T4, free T4 by dialysis (can help diagnose hypopituitarism)

After 1 week of age and before 6-9 months of age (mini-puberty)

Section titled “After 1 week of age and before 6-9 months of age (mini-puberty)”

Assess pituitary gonadotropin function

  • Pediatric LH
  • FSH

Assess gonadal function

  • Estradiol
  • Testosterone
  • Dihydrotestosterone
  • Anti-Müllerian hormone
    • reference range: boys > 30ng/mL; girls < 10ng/mL
    • Higher AMH than female range (XX individual) indicates Sertoli cells present (ovotesticular DSD)
    • AMH below typical male range (XY individual) indicates defect in testicular function
  • Skeletal survey
  • MRI of the Sella with and without contrast
  • Pediatric endocrinology
  • Pediatric urology
  • Psychology
  • Genetics
  • Social worker
  • Medical ethics

Congenital adrenal hyperplasia (CAH) treatment

Section titled “Congenital adrenal hyperplasia (CAH) treatment”
  • Fluid:
    • D5NS without K at 1-2x maintenance
    • consider 10mL/kg NS bolus if dehydrated
  • Glucocorticoids (hydrocortisone):
    • Start at 50mg/m2/day IV divided q4-6 hrs
  • Mineralocorticoirds:
    • Start fludrocortisone at 0.1mg qDay
  • NaCl supplement: Start at 3-4 mEq/kg/day (4mEq/mL solution)

For unilateral undescended (or non-palpable) testicle

Section titled “For unilateral undescended (or non-palpable) testicle”
  • No need to order ultrasound
  • Refere to Peds Urology for evaluation (there is a new hire at Fontana)
  • May wait until 3 months of age to refer as some will descend by that time
  • If there are othe rmalformations of the external genitalia (hypospadias) with undescended testicle(s), obtain labs as below an refer to Peds Urology without waiting until 3 months.

For bilateral undescended (or non-palpable) testicle

Section titled “For bilateral undescended (or non-palpable) testicle”
flowchart TD

A["Perform exam carefully and  
   repeatedly in a warm, relaxed state"] --> C["Yes"]
A --> B["No"]
B --> D["If the exam is unclear or uncertain,  
         it is best to <strong>obtain ultrasound</strong>  
         first, per Peds Endo"]
           
D --> E["If true bilateral undescended testes  
         on ultrasound report, endocrine work-
         up should be ordered next."]
         
C --> F["If the provider is comfortable  
         in making the clinical assessment 
         without aid of ultrasound, then  
         endocrine workup should be 
         ordered next."]
        
F --> G["<div align='left';>
        1. Testosteron, pediatric
        2. LH, pediatric
        3. FSH
        4. AMH (anti-Mullerian hormone)
        5. Karyotype
        6. 17-OH progesterone
            
        Call Peds Endo. 
        
        Do NOT discharge baby or give sex assignment  
        until workup evaluated by Peds Endo.
        </div>
"]

E --> G

D --> H["If testes are high scrotum or   
         low in the inguinal canal,  
         refer to Peds Urology for exam   
         and follow-up.  
         Newborn screen for CAH."]